Increasing children’s compliance with oral chemotherapy through partnership
Intended for healthcare professionals
Clinical Previous     Next

Increasing children’s compliance with oral chemotherapy through partnership

Maureen Theurer Charge Nurse/Practice Educator, Respite and Residential Service, Royal Hospital for Sick Children, Edinburgh
Deborah Tomlinson Macmillan Lecturer/Project Leader, Department of Nursing Studies, University of Edinburgh

Oral antimetabolites are the main drugs in the treatment of acute lymphoblastic leukaemia in children. However, children’s compliance with oral chemotherapy has been under question for many years. Nurses need to be aware of the possibility of non-compliance among this population and be involved in developing techniques and strategies in an attempt to minimise this problem. This article discusses how developing partnerships with families can help nurses tackle the issue of non-compliance in children.

Cancer Nursing Practice. 1, 6, 19-24. doi: 10.7748/cnp2002.07.1.6.19.c38

Correspondence

Deborah.Tomlinson@ed.ac.uk

Peer review

This article has been subject to double blind peer review

Want to read more?

RCNi-Plus
Already have access? Log in

or

3-month trial offer for £5.25/month

Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
  • Unlimited access to all 10 RCNi Journals
  • RCNi Learning featuring over 175 modules to easily earn CPD time
  • NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
  • Personalised newsletters tailored to your interests
  • A customisable dashboard with over 200 topics
Subscribe

Alternatively, you can purchase access to this article for the next seven days. Buy now


Are you a student? Our student subscription has content especially for you.
Find out more